Serina Therapeutics is a privately held biotechnology company located in Huntsville, Alabama. We have developed a proprietary, clinically-validated polymer technology based on the water-soluble polymer poly(oxazoline). We call it POZ for short. Please visit our website at www.serinatherapeutics.com and review the exciting work we are doing in vaccines, Parkinson's disease, pain, oncology and cannabinoid science.
We're tracking Serina Therapeutics, Inc.'s market expansion
How Serina Therapeutics, Inc.'s international expansion compares to its competitors
Serina Therapeutics, Inc.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Serina Therapeutics, Inc.You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Serina Therapeutics addressed FDA's requests regarding SER-252 program, targeting Q1 2026 for Phase 1b study initiation, pending FDA feedback.
Serina Therapeutics, a clinical-stage biotechnology company developing POZ Platform drug optimization technology, announced NYSE American has accepted its continued listing compliance plan.
Serina Therapeutics has granted stock to new employees under an inducement plan, likely to attract and retain talent.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Serina Therapeutics, Inc.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
